Kombucha Shows Promise in Managing Type 2 Diabetes

A pilot trial conducted by researchers at Georgetown University's School of Health, the University of Nebraska-Lincoln, and MedStar Health suggests that drinking kombucha, a fermented tea drink, may reduce fasting blood glucose levels in people with type 2 diabetes. The trial found that participants who consumed kombucha for four weeks had lower blood sugar levels compared to when they consumed a placebo beverage. This study provides promising evidence for a potential dietary intervention to help manage blood sugar levels in individuals with diabetes, and further research is needed to confirm and expand upon these findings.